HC-1119 Soft Capsules

HC-1119 · Hinova Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HC-1119 Soft Capsules, covering 2025-03-12 to 2025-03-12. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Evaluating the Efficacy and Safety of HC-1119 Soft Capsules in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). [Phase 3]

See pricing